Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

In the vaccine space, the Gates Medical Research Institute (Gates MRI) is running a Phase III trial of the M72/AS01E vaccine ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...

Tuberculosis: A Persistent Health Challenge Tuberculosis Treatment: Tuberculosis (TB) continues to pose a significant health ...

The World Health Organization (WHO) called on Tuesday for countries to step up action to end tuberculosis (TB) – one of the ...

Tuberculosis resurfaced into the national spotlight recently with a sudden resurgence of cases early this year.

India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess ...

In 2022, World Health Organization (WHO) recommended a shorter six-month, all-oral regimen known as BPaL (M), making ...